Furthermore, a positive correlation has been reported between the expression levels of ERBB2 and TOP2α [18, 20], with the TOP2α overexpression being frequently found in ERBB2-positive breast cancer patients[26-28]. This evidence concerns the gene TOP2A and breast carcinoma.